KYLEEN DAVIS: Open Payments
NPI 1053644062 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,109 in 68 payments from 22 companies in 2025. Trend: 2023 $1,148 · 2024 $1,575 · 2025 $2,109
Food & beverage: $1,922Education: $187
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $331 |
| Galderma Laboratories, L.P. | 10 | $314 |
| Arcutis Biotherapeutics, Inc. | 5 | $309 |
| GENZYME CORPORATION | 5 | $190 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| Amgen Inc. | 6 | $140 |
| ABBVIE INC. | 5 | $88 |
| Incyte Corporation | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| PFIZER INC. | 3 | $56 |
Products named: TREMFYA, DUPIXENT, Zoryve, NEMLUVIO, OTEZLA, SKYRIZI, OPZELURA, AKLIEF.
Industry payments across MD — which companies pay providers there.
